OncoKB数据来源包括FDA、NCCN、ASCO或ESMO会议论文、肿瘤领域专家共识和论文文献,以及cBioPortal,COSMI等公共数据库,共56种肿瘤相关的682个基因5425种改变以及对应的96种药物注释信息,每条信息经过临床基因组学注释委员会(Clinical Genomics Annotation Committee, CGAC)的定期审阅与修订。 进入OncoKB官网主页,可以看到OncoKB根...
Join us at the 21st Global Biomarkers and Clinical Research Summit to explore cutting-edge innovations, networking opportunities, and advancements in personalized medicine.
The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice. As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the ...
A medical technology company enabling precision medicine to become a reality in neuroscience research and development
Biomarkers in Clinical Research and Development, Biomarkers for Disorders, Techniques to Maximize Biomarker Identification, Biomarkers in Nano science, Cancer Biomarkers, Functional Transcriptomics and Profiling Techniques, Biomarkers in Toxicology, Biomarkers in Microbial Infections, Biomarkers in Drug Discovery ...
All-optical optoacoustics for clinical diagnostics The quality of three-dimensional optoacoustic images of subcutaneous microvasculature in patients can be enhanced by reducing the scan times of all-optical Fabry–Pérot scanners to a few seconds. ...
However, there are few known biomarkers that are robust enough to show true analytical and clinical value. Deep learning (DL)-based computational pathology can be used as a strategy to predict survival, but the limited interpretability and generalizability prevent acceptance in clinical practice. Here...
sufficient evidence must be provided that these were procured in line withWHO Guiding Principles on Human Cell, Tissue and Organ Transplantation. The source of the organs or tissues used in clinical research must be transparent and traceable. If your manuscript describes organ transplantation you must...
Research Briefing|18 June 2024 Molecular pathology markers of FTD and ALS in blood extracellular vesicles A lack of biomarkers for frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) hinders clinical trials of therapies for these disorders. We now show that blood extracellular vesicles...